poisar

Stock

ARS Pharmaceuticals, Inc. SPRY

$6.03+5.05%

Overview

SPRY market data

Price History

SPRY price chart · 1M
O
5.74
H
6.09
L
5.67
C
6.03
Vol
59,588.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$5.74
Previous Close
$5.74
Day High
$6.09
Day Low
$5.67
52 Week High
$10.86
52 Week Low
$5.00
7 Day Return
-5.34%
30 Day Return
+4.96%
90 Day Return
-35.85%
1 Year Return
-33.44%
Daily Notional Volume
$359.3K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.74
Diluted earnings per share over the trailing twelve months.
Beta
0.79
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-200.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.91 – $15.09
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $605.7M · P/B 10.08 · P/S 6.12.

Company News

10 captured
ARS Pharmaceuticals shares are trading lower after the company reported mixed Q2 financial results.Benzinga · Aug 14, 2026, 12:40 PM
Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Aug 14, 2026, 12:06 PM
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 14, 2026, 8:37 AM
ARS Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call TranscriptBenzinga · Aug 13, 2026, 9:17 PM
ARS Pharmaceuticals Q2 EPS $(0.63) Misses $(0.48) Estimate, Sales $33.658M Beat $31.321M EstimateBenzinga · Aug 13, 2026, 8:01 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)Globenewswire Inc · Aug 6, 2026, 8:15 PM
8-K filing — ARS Pharmaceuticals, Inc. (SPRY)SEC EDGAR · Jul 17, 2026, 8:02 PM
Can ARS Pharma's New CEO Unlock Neffy's Potential?Benzinga · Jul 9, 2026, 5:40 PM
ARS Pharmaceuticals CEO Richard Lowenthal To Depart, Effective July 6; President Donn Casale Named Successor, Effective July 7Benzinga · Jul 7, 2026, 8:40 PM
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On FridayBenzinga · Jun 26, 2026, 2:25 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock